Cited by 528

The DOI matches its Crossref record.

Syk tyrosine kinase required for mouse viability and B-cell development

Cheng, Alec M., Rowley, Bruce, Pao, William, Hayday, Adrian, Bolen, Joseph B., Pawson, Tony·1995·Nature

Abstract

The Syk cytoplasmic protein-tyrosine kinase has two amino-terminal SH2 domains and a carboxy-terminal catalytic domain. Syk, and its close relative ZAP-70, are apparently pivotal in coupling antigen- and Fc-receptors to downstream signalling events. Syk associates with activated Fc receptors, the T cell receptor complex and the B-cell antigen-receptor complex (BCR) in immature and mature B lymphocytes. On receptor activation, the tandem SH2 domains of Syk bind dual phosphotyrosine sites in the conserved ITAM motifs of receptor signalling chains, such as the immunoglobulin alpha and beta-chains of the BCR, leading to Syk activation. Here we have investigated Syk function in vivo by generating a mouse strain with a targeted mutation in the syk gene. Homozygous syk mutants suffered severe haemorrhaging as embryos and died perinatally, indicating that Syk has a critical role in maintaining vascular integrity or in wound healing during embryogenesis. Analysis of syk-/- lymphoid cells showed that the syk mutation impaired the differentiation of B-lineage cells, apparently by disrupting signalling from the pre-BCR complex and thereby preventing the clonal expansion, and further maturation, of pre-B cells.

Overview

Integrity signals

Registry

Crossref · 10.1038/378303a0

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 31

  1. Taniguchi, T. et al. J. biol. Chem. 266, 15790–15796 (1991). · DOI
  2. Chan, A. C., Iwashima, M., Turck, C. W. & Weiss, A. Cell 71, 649–662 (1992). · DOI
  3. DeFranco, A. L. Curr. Opin. cell. Biol. 7, 163–175 (1995). · DOI
  4. Takata, M. et al. EMBO J. 13, 1341–1349 (1994). · DOI · Paper page
  5. Durden, D. L. & Liu, Y. B. Blood 84, 2102–2108 (1994). · DOI
  6. Chan, A. C. et al. J. Immun. 152, 4758–4766 (1994). · DOI
  7. Hutchcroft, J. E., Harrison, M. L. & Geahlen, R. L. J. biol. Chem. 267, 8613–8619 (1992). · DOI
  8. Rowley, R. B., Burkhardt, A. L., Chao, H.-G., Matsueda, G. R. & Bolen, J. B. J. biol. Chem. 270, 11590–11594 (1995). · DOI
  9. Leveen, P. et al. Genes Dev. 8, 1875–1887 (1994). · DOI
  10. Soriano, P. Genes Dev. 8, 1888–1896 (1994). · DOI
  11. Taniguchi, T. et al. J. biol. Chem. 268, 2277–2279 (1993). · DOI
  12. Rezaul, K., Yanagi, S., Sada, K., Taniguchi, S. & Yamamura, H. Fibrosis Hemostas. 72, 937–941 (1995).
  13. Clark, E. A., Shattil, S. J., Ginsberg, M. H., Bolen, J. & Brugge, J. S. J. biol. Chem. 269, 28859–28864 (1994). · DOI
  14. Sninkai, Y. et al. Cell 68, 855–867 (1992). · DOI
  15. Arpaia, E., Shahar, M., Dadi, H., Cohen, A. & Roifman, C. M. Cell 76, 947–958 (1994). · DOI
  16. Chan, A. C. et al. Science 264, 1599–1601 (1994). · DOI
  17. Hayakawa, K., Hardy, R. R., Herzenberg, L. A. & Herzenberg, L. A. J. exp. Med. 161, 1554–1568 (1985). · DOI
  18. Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. & Hayakawa, K. J. exp. Med. 173, 1213–1225 (1991). · DOI
  19. Kitamura, D. et al. Cell 69, 823–831 (1992). · DOI · Paper page
  20. Misener, V., Downey, G. P. & Jongstra, J. Int. Immun. 3, 1129–1136 (1991). · DOI
  21. Karasuyama, H., Kudo, A. & Melchers, F. J. exp. Med. 172, 969–979 (1992). · DOI
  22. Decker, D. J., Boyle, N. E., Koziol, J. & Klinman, N. R. J. Immun. 146, 350–359 (1991). · DOI
  23. Spanopoulou, E. et al. Genes Dev. 8, 1030–1042 (1994). · DOI
  24. Young, F. et al. Genes Dev. 8, 1043–1057 (1994). · DOI
  25. Papavasiliou, F., Misulovin, Z., Suh, H. & Nussenzweig, M. C. Science 268, 408–411 (1995). · DOI
  26. Gu, H., Kitamura, D. & Rajewsky, K. Cell 65, 47–54 (1991). · DOI
  27. Haasner, D., Rolink, A. & Melchers, F. Int. Immun. 6, 21–30 (1994). · DOI
  28. Joyner, A. L. in Gene targeting. A practical approach (IRL, Oxford, 1993).
  29. Mallick, C. A., Dudley, E. C., Viney, J. L., Owen, M. J. & Hayday, A. C. Cell 73, 513–519 (1993). · DOI
  30. Carlsson, L., Overmo, C. & Holmberg, D. Eur. J. Immun. 22, 71–78 (1992). · DOI
  31. Chukwuocha, R. U., Hartman, A. B. & Feeney A. J. Immunogenet. 40, 76–78 (1994). · DOI

Cited by

Sorted by citations

See all 528

Metadata

Authors
Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., & Pawson, T.
Venue
Nature
Published
1995-11-16
Volume
378
Issue
6554
Pages
303-306
ISSN
  • 0028-0836
  • 1476-4687
Cited by
528
References
0
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review